Abbott Labs. - Feb., p. 36; Mar., p. 65, 72, 74; Apr., p. 106, 107; May, p. 107; July, p. 169; Aug., p. 203; Sep., p. 230, 235; Nov., p. 297
Abundant Life Clinics - May, p. 101
Academic Medical Center - Nov., p. 292
ACT UP Golden Gate - Nov., p. 300
ACT-UP New York - May, p. 108
ACT-UP San Francisco - July, p. 171
Adams Labs., Inc. - May, p. 107
Advanced Plant Pharmaceuticals, Inc. - Oct., p. 268
Advanced Viral Res. Corp. - June, p. 138; Oct., p. 268; Dec., p. 331
Agouron Pharmaceuticals, Inc. - Feb., p. 40; Mar., p. 74; June, p. 137; July, p. 164; Sep., p. 234; Oct., p. 263, 270; Nov., p. 295, 298; Dec., p. 331
AIDS Action Council - Nov., p. 298
AIDS Clinical Trials Group (ACTG) - Aug., p. 203; Sep., p. 230
AIDS drugs buyers clubs - Aug., p. 197
AIDS ReSEARCH Alliance - June, p. 136
AIDS Treatment Data Network - May, p. 108
Akzo Nobel Pharma - June, p. 129
Albany Medical Center - Dec., p. 329
Albert Einstein College of Medicine - Mar., p. 72
Amarillo Biosciences, Inc. - May, p. 101
American Academy of Pediatrics - Dec., p. 329
American Home Products Corp. - Feb., p. 33, 41; May, p. 103, 105; Sep., p. 235; Oct., p. 260; Nov., p. 297
American Medical Association - Feb., p. 43; June, p. 140; Aug., p. 205
Amgen, Inc. - June, p. 141; Dec., p. 335
Apollon, Inc. - May, p. 103; Oct., p. 269; Dec., p. 329
Aquila Biopharmaceuticals, Inc. (see also Cambridge Biotech Corp.) - Aug., p. 202
Arkopharma Labs. - Aug., p. 197
Aronex Pharmaceuticals, Inc. - May, p. 107; Oct., p. 265; Nov., p. 298
ArQule, Inc. - Apr., p. 106
Arris Pharmaceutical Corp. - Sep., p. 234; Oct., p. 270
Astra USA, Inc. - Feb., p. 40
Avid Corp. - Apr., p. 101
Aviron, Inc. - Feb., p. 44; Oct., p. 260
Barr Labs. - Feb., p. 43
Baxter International Inc. - Sep., p. 234
Behringwerke AG - Mar., p. 73; Apr., p. 107
BioChem Pharma Inc. - Mar., p. 70; May, p. 105, 107; June, p. 38, 142; July, p. 168, 171; Aug., p. 193, 205; Nov., p. 290, 300
Biocine Corp. (use Chiron Corp.)
Biocontrol Technology, Inc. - Oct., p. 267
Biogen Inc. - May, p. 109; Nov., p. 301
Biological and Popular Culture, Inc. - Sep., p. 232
bioMerieux S.A. - Apr., p. 106
BioTechnology General Ltd. - Oct., p. 270
Boehringer Ingelheim Corp. - Mar., p. 71; May, p. 107; July, p. 163; Aug., p. 200; Dec., p. 326
Boehringer Mannheim GmbH - Oct., p. 261; Dec., p. 328, 331
Boehringer Mannheim Therapeutics - June, p. 135
Boyce Thompson Institute - July, p. 174
Brazil, Health Ministry - Nov., p. 297
Bristol-Myers Squibb Co. - Feb., p. 34, 44; Mar., p. 68, 72, 74; Apr., p. 102; June, p. 137, 139; Nov., p. 296; Dec., p. 335
British Biotech Pharmaceuticals, Ltd. - May, p. 106; Nov., p. 298
Burroughs Wellcome Co. (see also Glaxo Wellcome) - Oct., p. 272
Calgene, Inc. - Apr., p. 107
Calypte Biomedical Corp. - Aug., p. 203
Cambridge Biotech Corp. - Feb., p. 45; Apr., p. 106; Aug., p. 202
Canadian HIV Trials Network - Apr., p. 100, 102
Cantab Pharmaceuticals PLC - Feb., p. 45; June, p. 133; July, p. 170; Dec., p. 324
CEL-SCI Corp. - June, p. 141; July, p. 168; Nov., p. 297
Cell Genesys, Inc. - Feb., p. 41; Apr., p. 101
Cell Med Inc. - June, p. 141
Center for Blood Research, Inc. - June, p. 141
Centers for Disease Control and Prevention (CDC) - Feb., p. 42; May, p. 107; Sep., p. 235
Centre for Genetic Engineering & Biotechnology, Cuba - Dec., p. 330
ChildrenŐs Hospital Medical Center - Oct., p. 267
Chiron Behring - Sep., p. 232
Chiron Corp. - Feb., p. 35; Mar., p. 73, 74; Apr., p. 107; June, p. 136, 139, 140; Aug., p. 203, 205; Sep., p. 227, 232, 238; Oct., p. 257; Dec., p. 325
Chiron Vision Corp. - Mar., p. 66
Chiroscience Ltd. - May, p. 102
Ciba-Geigy AG (see also Novartis) - Apr., p. 103; Dec., p. 335
Clinical Care Options for HIV Program - June, p. 140
Colorado State University - June, p. 134
Columbia Laboratories, Inc. - June, p. 137
Community Research Institute of New England - Apr., p. 105
Corange Ltd. (see also Boehringer Mannheim) - June, p. 135; Oct., p. 261
Coulter Corp. - June, p. 139
CSL Ltd. - Aug., p. 199
Cytel Corp. - June, p. 132; Dec., p. 330
CytoDyn, Inc. - Dec., p. 334
Dana-Farber Cancer Inst. - June, p. 134
Denver Community Program for Clinical Research - May, p. 107
Deutsches Krebsforschungszentrum - July, p. 174
Dimethaid Research Inc. - Oct., p. 262
Direct Access Diagnostics - June, p. 139
Dissatisfied Parents Together - Sep., p. 235
Drug Innovation and Design Inc. - Sep., p. 234
Duke University - Dec., p. 327
DuPont Merck Pharmaceutical Co. - Apr., p. 101; Aug., p. 199; Sep., p. 231; Nov., p. 300
Eisai Co. Ltd. - Aug., p. 195
Emory University - Apr., p. 101; May, p. 108; June, p. 142; Aug., p. 205
Enzo Biochem Inc. - Mar., p. 72; Apr., p. 107
Enzon, Inc. - Nov., p. 302
Epitope, Inc. - June, p. 139
European Collaborative Study - Feb., p. 42
Evans Medical Ltd. - Oct., p. 260
Federal Trade Commission - May, p. 109
Forum for Collaborative HIV Research - Aug., p. 201
France - Mar., p. 72
Gene Shears Pty. Ltd. - Feb., p. 41
Genelabs Technologies, Inc. - Dec., p. 331
Genentech, Inc. - Feb., p. 44; Mar., p. 68; June, p. 136; Oct., p. 269
Genenvax, Inc. - Mar., p. 68; Oct., p. 269
General Injectables & Vaccines, Inc. - May, p. 107; Sep., p. 232
Genetic Therapy, Inc. - Mar., p. 78
Genetics Institute - Nov., p. 297
Georgetown University - July, p. 174
German Cancer Research Center - July, p. 174
Gibraltar Labs. - Apr., p. 104
Gilead Sciences, Inc. - Feb., p. 39, 41; Mar., p. 74; May, p. 103, 104; June, p. 133, 137; July, p. 161; Aug., p. 195, 202; Sep., p. 226, 231, 234; Oct., p. 263, 271; Dec., p. 321
Glaxo Wellcome Co./PLC - Feb., p. 42, 43; Mar., p. 70; Apr., p. 104; May, p. 107; June, p. 38, 131; July, p. 168, 169, 170, 172; Aug., p. 193, 200, 202, 205; Sep., p. 230; Oct., p. 272; Nov., p. 290, 293, 296, 299, 301; Dec., p. 327
Harvard Medical School - Sep., p. 235
Hayashibara Biochemical Labs. - May, p. 101
Helix BioPharma Corp. - June, p. 136
HemispheRx Biopharma Inc. - June, p. 136
HemoCleanse, Inc. - Oct., p. 267
HIV-DOCS - May, p. 108
HIV/AIDS Information Center - Aug., p. 205
Hoechst AG - Mar., p. 73
Hoechst Marion Roussel - Apr., p. 101
Hoffmann-La Roche Inc./Ltd. - Feb., p. 40, 41, 44; Mar., p. 70, 73, 74; Apr., p. 107; May, p. 97, 104, 109; June, p. 129; Aug., p. 197, 203, 205; Sep., p. 229, 230, 231, 234, 238; Oct., p. 266; Nov., p. 295, 296, 297, 298, 302; Dec., p. 321, 322
Hybridon, Inc. - Apr., p. 103; Aug., p. 196; Oct., p. 266
ICN Pharmaceuticals, Inc. - Sep., p. 236; Oct., p. 269
IDT, Inc. - Oct., p. 267
Immune Response Corp. - Apr., p. 105; May, p. 104; Aug., p. 203; Oct., p. 268; Nov., p. 296, 298
Immuno International AG - Sep., p. 234
Industria Farmaceutica Andromaco - Aug., p. 200
Innovir Laboratories, Inc. - Aug., p. 201; Dec., p. 331
InSource, Inc. - Sep., p. 232
Institut Nationale de la Sante et de la Rech. Med. (INSERM) - June, p. 141
Institut Pasteur - Feb., p. 45; Oct., p. 269
Institute of Human Virology - Nov., p. 301
Interferon Sciences, Inc. - May, p. 101, 105; Aug., p. 200
International AIDS Society-USA - June, p. 131
International AIDS Vaccine Initiative - Aug., p. 201
International Commission on Taxonomy of Viruses - Feb., p. 43
International Gene Group, Inc. - June, p. 136
International Murex Technologies Corp. - Sep., p. 238
Isis Pharmaceuticals, Inc. - Aug., p. 195; Oct., p. 267
Janssen Pharmaceutica - Feb., p. 45
Janssen Research Foundation - Aug., p. 193
Japan Energy Co., Ltd. - July, p. 172
Japan Tobacco Inc. - Oct., p. 270; Nov., p. 295
John Radcliffe Hospital - May, p. 104
Johnson & Johnson Co. - Feb., p. 41; Apr., p. 107; June, p. 139; Sep., p. 238
Kaiser Family Foundation - Sep., p. 237
Kenya Medical Research Institute - May, p. 101
Keystone Center - Aug., p. 201
Kissei Pharmaceutical Co., Ltd. - Feb., p. 42; Sep., p. 230
Kyoto Pharmaceutical University - July, p. 172
Laboratoire Besnouin S.A. - Feb., p. 45
Laboratoire Homeopathique Spagyrique SA - June, p. 138
LeukoSite, Inc. - Dec., p. 330
Lidak Pharm. Inc. - Feb., p. 44; Apr., p. 104; Aug., p. 200; Dec., p. 335
Life Technologies, Inc. - June, p. 129
Lippincott-Raven Publishers - Nov., p. 301
Massachusetts Inst. of Technology (MIT) - Mar., p. 78
Massachusetts Public Health Biologic Labs - Feb., p. 33
Massachusetts (State) - May, p. 106
Matrix Pharmaceutical, Inc. - Mar., p. 74; June, p. 132
Mayo Clinic - May, p. 104
Medarex, Inc. - Apr., p. 102
Medeva PLC - Feb., p. 45; May, p. 107; Oct., p. 260; Nov., p. 301
Medical School of Hannover - Aug., p. 202
MedImmune, Inc. - Feb., p. 33; Mar., p. 72; May, p. 105; June, p. 142; July, p. 174; Aug., p. 200; Dec., p. 325
Medivir AB - Apr., p. 106
Medscape - July, p. 173
Merck & Co. - Feb., p. 37; Apr., p. 97, 98; May, p. 99; June, p. 137; July, p. 172; Aug., p. 203; Nov., p. 297, 298, 299, 301
Microgen, Inc. - Apr., p. 104
MicroGeneSys, Inc. - Apr., p. 100; May, p. 102
Mitsubishi Chemical Corp. - Feb., p. 39; May, p. 108
Mundipharma - May, p. 105
Murex Diagnostics Ltd. - Apr., p. 107
Muzak Ltd. - Nov., p. 300
NABI - Feb., p. 42; Mar., p. 72; Sep., p. 235; Dec., p. 325
Nation of Islam - May, p. 101
National AIDS Treatment Advocacy Project - May, p. 108
National Cancer Institute (NCI) - Feb., p. 43; May, p. 107
National Institute of Allergy and Infectious Diseases (NIAID) - Feb., p. 42; Mar., p. 74, 76; 78, May, 98, 101, 102; July, p. 166; Aug., p. 196; Sep., p. 227, 233; Oct., p. 257
National Institutes of Health (NIH) - June, p. 140, 142; July, p. 174; Aug., p. 206; Nov., p. 298; Dec., p. 333
National Library of Medicine (NLM) - July, p. 173
National Vaccine Information Center (NVIC) - Dec., p. 329
New York Academy of Medicine - May, p. 108
New York Blood Center - May, p. 106
New York University Medical Center - July, p. 165
NeXstar Pharmaceuticals Inc. - May, p. 107; June, p. 135
AIDS Research and Reference Reagent Program - June, p. 141
Office of AIDS Research (OAR), NIH - Mar., p. 76
Nippon Zeon Co., Ltd. - July, p. 168
Northeastern Ohio Universities College of Medicine - Nov., p. 297
Northwestern University Medical School - Nov., p. 299
Nottingham University - Apr., p. 104
Novartis AG - Apr., p. 103; Dec., p. 335
Oclassen Pharmaceuticals Inc. - Nov., p. 297
Oncogene Science Inc. - May, p. 105; June, p. 142; Aug., p. 201
OncoRx, Inc. (use VION Pharmaceuticals, Inc.) - Feb., p. 42
OraVax, Inc. - May, p. 103; Aug., p. 199
Organon Teknika - Apr., p. 107
Ortho Diagnostic Systems, Inc. - Apr., p. 107; Sep., p. 238
Oxo Chemie GmbH - Oct., p. 262
Paracelsian, Inc. - Dec., p. 323
Pasteur-Merieux Connaught - Mar., p. 74, 79; Apr., p. 100; May, p. 105; Aug., p. 203; Sep., p. 235; Nov., p. 293
Penciclovir Topical Collaborative Study Group - Sep., p. 225
Pennsylvania State University - July, p. 174; Aug., p. 199
Perkin-Elmer Corp. - Sep., p. 238; Oct., p. 266
Pharma Pacific Management Pty. Ltd. - May, p. 101
Pharmacia & Upjohn, Inc. - Feb., p. 38; Apr., p. 103, 105; July, p. 172; Aug., p. 195, 203; Nov., p. 300; Dec., p. 332
Progenics Pharmaceuticals, Inc. - July, p. 165
Promega Corp. - Nov., p. 302
Protein Design Labs. - Oct., p. 261; Dec., p. 328
Purdue Pharma - May, p. 105
PWA Health Group - May, p. 108
Quantum Health Resources - May, p. 106
Quidel Corp. - Apr., p. 104
Recombinant DNA Advisory Committee (RAC), NIH - June, p. 140
Research Foundation for Microbial Dis. of Osaka Univ. - Apr., p. 107
Resolve Medical Marketing, Inc. - Sep., p. 232
RGene Therapeutics, Inc. - Mar., p. 79
Ribi ImmunoChem Research, Inc. - Feb., p. 45
RiboGene, Inc. - July, p. 173
Ribonetics GmbH - June, p. 138
Ribozyme Pharmaceuticals Inc. - June, p. 140
Rio Pharmaceuticals - Apr., p. 104
Rockefeller Foundation - Aug., p. 201
Rockefeller University - July, p. 165, 173
Roxane Laboratories, Inc. (use Boehringer Ingelheim Corp.)
Royal Thai Army - Aug., p. 201
Sandoz Corp./Ltd. (see also Novartis) - Mar., p. 78; Apr., p. 102, 103; Oct., p. 261; Dec., p. 327, 335
Sanofi Winthrop Inc. - Oct., p. 269
Schering-Plough Corp. - Nov., p. 298; Dec., p. 335
Schering-Plough K.K. - Nov., p. 302
SciClone Pharmaceuticals, Inc. - Apr., p. 104; July, p. 167; Aug., p. 194; Sep., p. 229; Oct., p. 264; Nov., p. 291, 302
Scripps Research Institute - Aug., p. 201
Searle, G.D. & Co. - July, p. 169; Oct., p. 270
Sequus Pharmaceuticals Inc. - June, p. 141
Seradyn Corp. - Aug., p. 203
Serono Laboratories, Inc. - Sep., p. 236
Sheffield Medical Technologies Inc. - June, p. 141
SmithKline Beecham Biologicals - Apr., p. 104; July, p. 170; Sep., p. 232; Oct., p. 270; Dec., p. 331
SmithKline Beecham Corp. - Feb., p. 44; Mar., p. 73; May, p. 109; June, p. 139; Sep., p. 225, 228, 234, 235; Oct., p. 264, 270; Nov., p. 289; Dec., p. 332, 334
Solvay Pharmaceuticals, Inc. - Sep., p. 235
Somatix Therapy Corp - Mar., p. 78
SRA Technologies, Inc. - Dec., p. 329
Stadtlanders Pharmacy - May, p. 99; Nov., p. 299
State University of New York (SUNY) - Apr., p. 107
Storz Instruments Co. - Feb., p. 41
Studies of the Ocular Complications of AIDS (SOCA) - May, p. 104; Oct., p. 261
Sylka Managing Co. - Nov., p. 296
SyStemix, Inc. - Apr., p. 102; Dec., p. 327
T Cell Sciences, Inc. - Apr., p. 106
Terrapin Technologies Inc. - Apr., p. 101
Triangle Pharmaceuticals, Inc. - Feb., p. 39; May, p. 108
Trinity Medical Group - Apr., p. 105; Oct., p. 268
Tulane University - Feb., p. 43; May, p. 108
United Biomedical Inc. - Apr., p. 103, 107
United Nations Global Program on HIV/AIDS - June, p. 137
Univax Biologics, Inc. (use NABI)
University of Alabama - June, p. 135
University of Bern - Sep., p. 235
University of California, Davis - July, p. 174
University of Georgia - May, p. 108
University of Leiden - June, p. 142
University of Maryland - Nov., p. 301
University of Massachusetts School of Medicine - Sep., p. 234
University of Michigan - Apr., p. 102; Oct., p. 260
University of Minnesota - Oct., p. 272
University of Nebraska Medical Center - Nov., p. 301
University of Pittsburgh Medical Center - June, p. 136
University of Rochester - July, p. 174
University of Washington - Apr., p. 108; May, p. 106
U.S. Bioscience, Inc. - June, p. 133
U.S. Patent and Trademark Office - Feb., p. 44; Nov., p. 302
U.S. Supreme Court - Feb., p. 43
Verex Laboratories, Inc. - July, p. 170
Vertex Pharmaceuticals Inc. - Feb., p. 42; June, p. 131; July, p. 169; Sep., p. 230; Oct., p. 263
Vical Inc. - May, p. 105
VIMRx Pharmaceuticals, Inc. - June, p. 138; Oct., p. 268; Dec., p. 331
VION Pharmaceuticals, Inc. - Feb., p. 42; Aug., p. 205
Viragen Inc. - May, p. 106
Viridae Clinical Sciences, Inc. - Aug., p. 205
ViroPharma, Inc. - May, p. 102; Oct., p. 269
Viru-Tech Ltd. - Nov., p. 298
Virus Research Institute, Inc. - Oct., p. 266; Nov., p. 293
Walter Reed Army Inst. of Research (WRAIR) - May, p. 102
Warner-Lambert Co. - July, p. 173; Aug., p. 200; Dec., p. 330, 332
Washington University School of Medicine - May, p. 104
Watson Pharmaceuticals Inc. - Nov., p. 297
Wyeth-Ayerst Labs. (use American Home Products Corp.)
XTL Biopharmaceuticals - Nov., p. 300
Yale University - Feb., p. 42; Aug., p. 205
Yamanouchi Pharmaceutical Co., Ltd. - June, p. 141
Yamasa Corp. - June, p. 139